
JJM had tierce options: (1) set up a meeting with the FDA and argue their persona for the treatment and ginmill claims and thereby preserve the probability to be first to market, (2) drop the cake claim and thus affix the chances of being first to market, or (3) give up the opportunity to be first to market and improve their chances of FDA approval by collecting additional info to support their claims. See Exhibit 3 listing pros and cons of to from each one one option. Analyses In smell at the potential customers and market for famotidine AC, it seems the customers have pack a need for a result that lasts longer than the OTC antacids already on the market and that alike help counteract heartburn symptoms before the start. Pepcid AC could be really competitive in the tralatitious OTC antacid valued at $750 million in 1994 if it kindle meet the demands of the consumers that typical use these products. According, JJM research just about 28%-34% of all OTC antacids would consider substituting Pepcid AC for...If you want to observe a full essay, order it on our website: Ordercustompaper.com
If you want to get a full essay, wisit our page: write my paper
No comments:
Post a Comment